Showing results (71-80 of 485) with videos related to
Sort By:
Pageof 49
Contrast Media & Molecular Imaging|July 9, 2019
Highly Biocompatible Nanoparticles of Au@Fluorescent Polymers as Novel Contrast Agent for In Vivo Bimodality NIR Fluorescence/CT ImagingMengshu Zhang, Jinlei Liu, Guannan WangNanoscale|May 26, 2018
A theranostic nanoplatform: magneto-gold@fluorescence polymer nanoparticles for tumor targeting T1&T2-MRI/CT/NIR fluorescence imaging and induction of genuine autophagy mediated chemotherapyGuannan Wang, Kun Qian, Xifan MeiLin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Journal of Clinical Otorhinolaryngology Head and Neck Surgery|December 11, 2012
[Chronic suppurative otitis media induced subarachnoid hemorrhage: case analysis]Guannan Wang, Wenqiang Yang, Yi ZhangSheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology|August 5, 2020
[Current progress in antimicrobial peptides against bacterial biofilms]Wenbo Wang, Guannan Wang, Shasha CaiRSC Advances|April 28, 2022
Magnetic-gold theranostic nanoagent used for targeting quad modalities T 1 & T 2-MRI/CT/PA imaging and photothermal therapy of tumoursJinlei Liu, Dan Wang, Guannan WangCancer Biology & Therapy|September 1, 2005
Role of p53/p21(Waf1/Cip1) in the regulation of polyamine analogue-induced growth inhibition and cell death in human breast cancer cellsYi Huang, Allison Pledgie, Ethel Rubin, et al.The Journal of Molecular Diagnostics : JMD|August 28, 2009
MethySYBR, a novel quantitative PCR assay for the dual analysis of DNA methylation and CpG methylation densityPang-Kuo Lo, Hanano Watanabe, Pi-Chun Cheng, et al.Breast Cancer Research and Treatment|July 4, 2012
Intraductally administered pegylated liposomal doxorubicin reduces mammary stem cell function in the mammary gland but in the long term, induces malignant tumorsYong Soon Chun, Takahiro Yoshida, Tsuyoshi Mori, et al.Cancer Biology & Therapy|May 28, 2010
Basal-like breast cancer displays distinct patterns of promoter methylationJi Shin Lee, Mary Jo Fackler, Jae Hyuk Lee, et al.Cancer Biology & Therapy|December 24, 2014
A breast cancer cell microarray (CMA) as a rapid method to characterize candidate biomarkersXinyan Wu, Muhammad S Zahari, Santosh Renuse, et al.Pageof 49